This protocol describes a simple and efficient way to label specific cell surface proteins with biophysical probes on mammalian cells. Cell surface proteins tagged with a 15-amino acid peptide are biotinylated by Escherichia coli biotin ligase (BirA), whereas endogenous proteins are not modified. The biotin group then allows sensitive and stable binding by streptavidin conjugates. This protocol describes the optimal use of BirA and streptavidin for site-specific labeling and also how to produce BirA and monovalent streptavidin. Streptavidin is tetravalent and the cross-linking of biotinylated targets disrupts many of streptavidin's applications. Monovalent streptavidin has only a single functional biotin-binding site, but retains the femtomolar affinity, low off-rate and high thermostability of wild-type streptavidin. Site-specific biotinylation and streptavidin staining take only a few minutes, while expression of BirA takes 4 d and expression of monovalent streptavidin takes 8 d.
INTRODUCTION
It is a great chemical challenge to modify a single protein amid the many others present on the mammalian cell surface. A number of approaches have been taken to tackle this 1 . We have focused on using enzymes to achieve high specificity and rapid labeling. In particular, we have adopted the enzyme biotin ligase (BirA) from Escherichia coli [2] [3] [4] . Site-specific biotinylation is an efficient, rapid and sensitive way for imaging proteins in mammalian cells. It is also effective for protein detection by western blot 3 and for protein isolation with exceptional purity 5 . Proteins that are genetically fused with only a 15-amino acid recognition sequence (the acceptor peptide or AP, also known as Avitag) are recognized by BirA 6 . Biotinylation then allows sensitive recognition by streptavidin conjugated to a range of biophysical probes, including small molecule fluorophores or quantum dots ( Fig. 1) , which can allow imaging of the target protein at the single molecule level 3, 7, 8 .
Diversity of applications
BirA labeling. BirA labeling has been successfully applied to a wide range of cell surface proteins, with AP insertion at the N terminus, C terminus or within loops 7 of the protein and is specific in all the mammalian cell types we have tested, including human, mouse, rat and hamster cell lines, and primary neuron cultures 3 . BirA labeling has also been successful in nonmammalian cells [8] [9] [10] [11] . BirA labels the AP-tag specifically in different cellular compartments: at the cell surface 3 , in the endoplasmic reticulum [12] [13] [14] ( Fig. 1b) , in the cytosol and in the nucleus 15 . BirA labeling may also be used in living animals, for example in a transgenic mouse expressing cytosolic BirA 16 .
The advantage of streptavidin labeling is its high affinity and stability 17 ; hence, the benefit of streptavidin labeling over Ab labeling will be most evident for proteins expressed at low levels or where long-term imaging is desired. BirA may also be used to study protein dynamics, either by labeling proteins both before and after a stimulus using streptavidins conjugated to differently colored fluorophores 3 , or by biotinylating surface proteins, allowing time for internalization, and then using streptavidin to quantify how much biotinylated receptor remains on the cell surface. In nonimaging contexts, the fast on-rate and high stability of the streptavidin-biotin interaction mean that BirA biotinylation allows isolation of protein complexes with greatly improved signal to noise ratios 5, 16 . An alternative protocol using biotin ligase involves endogenous mammalian biotin ligase (holocarboxylase synthetase) recognition of a small protein domain, for targeting probes in living animals, such as for MRI 18 . This protocol has the advantage that there is no need to introduce a new biotin ligase but has the disadvantages of the increased size of the acceptor domain (129 amino acids), relative to the AP for BirA, the restricted location of attachment of this acceptor domain and the inability to control when biotinylation occurs 18 .
Specific biotinylation can also be achieved in cells using reaction with C-terminal Cys generated by intein cleavage 19 , but this approach limits the site of biotin attachment to the C terminus of the protein, requires incubation of cells with high concentration of thiols, which disrupts the folding of many proteins, and may be restricted to cytosolic labeling.
Monovalent streptavidin. Receptor cross-linking can affect receptor signaling function 20 . Cross-linking can also change the dynamics of movement within the membrane 21, 22 and internalization from the membrane. Cross-linking can be avoided to some extent using ligand in excess, but if ligand dissociates over time or new pools of receptor are exocytosed, cross-linking becomes problematic again. This has long been a problem with the use of antibodies in labeling. Some studies have used Fab Ab fragments that will not cross-link, but very often dissociate rapidly 23 , making study problematic for more than a few minutes. In the case of BirA labeling, using excess wild-type streptavidin will sometimes be sufficient to avoid significant cross-linking of biotinylated proteins (Fig. 2) . For more reliable studies we suggest using monovalent streptavidin.
Streptavidin is a tetramer containing four biotin-binding sites, each with femtomolar affinity for biotin 17 . Mutations that make streptavidin monomeric reduce biotin-binding affinity by B10 4 -fold 24, 25 . Similarly, monomeric avidin has an enormously reduced biotinbinding affinity 26 . In our approach, we kept the streptavidin tetramer intact but inactivated three of the biotin-binding sites by mutation 4 , to give a monovalent streptavidin containing a single biotin-binding site with an affinity equivalent to the original tetramer (Fig. 2a) . Monovalent streptavidin is purified by refolding of inclusion bodies expressed in E. coli and a single nickel affinity column (Fig. 2c) . We give methods for the application of monovalent streptavidin in cellular imaging, but monovalent streptavidin is also likely to find application in constructing protein arrays, protein delivery in living animals where cross-linking can activate complement destruction of the cell 27 and in nanotechnology for controlled assembly of biological 28 and nonbiological components 29 on the nanoscale.
Limitations
The size of streptavidin. Streptavidin is 56 kDa, and even though this is significantly smaller than an IgG Ab (160 kDa), the size still has the potential to affect protein function. Where possible, controls should be performed to determine this. For example, one can test that binding of streptavidin to AP-tagged epidermal growth factor (EGF) receptor does not change Tyr phosphorylation in response to EGF. We have developed an alternative to streptavidin labeling, where BirA transfers a ketone analog of biotin. The ketone group can then be specifically labeled with a hydrazide linked to a small molecule of interest, such as a fluorophore or a photocrosslinker 2 . Therefore, the overall change in protein size is very small, although the kinetics of hydrazide labeling mean that this approach lacks sensitivity. We do not provide a protocol for ketone labeling here. An alternative approach, based on the use of lipoic acid ligase, allows labeling with a similar small increase in protein size but with more sensitivity than ketone labeling 30 . Exogenous expression. Unlike for Ab labeling of endogenous proteins, the AP-fusion must be transfected into the cell, raising the specter of artifacts from overexpression. One can either test that overexpression does not significantly change the cell behavior of interest, or one can control transgene expression to endogenous levels by the use of suitable promoters or selection of appropriately expressing stable cell lines.
Experimental design
To ensure the specificity of your signal, valuable negative controls are either to perform the above procedure without added or cotransfected BirA, or to pretreat the streptavidin with excess free biotin so that there should be no binding to biotinylated cellular proteins. If you are using a fluorescent protein cotransfection marker, streptavidin staining should be restricted to the cells expressing the fluorescent protein. However, note that the correlation between the cells that are transfected with two different plasmids is not always perfect. The best streptavidin conjugate depends on the usage of filters for your microscope. We have always had the best results with streptavidin-Alexa Fluor 568 (similar spectrum to Texas Red) which is bright and emits well away from cell autofluorescence. Streptavidin-fluorescein and streptavidin-Texas Red gave much poorer signals. Streptavidin-quantum dots will only be better for general imaging than Alexa Fluor 568 under these circumstances: (i) if you have a broad excitation filter particularly for quantum dots, as recommended by Invitrogen; (ii) if the cells are not expressing high levels of cyan fluorescent protein or yellow fluorescent protein, which can bleed into the quantum dot channel more than one would expect; or (iii) if you want to image at the single molecule level 3 . Avidin conjugates will bind to biotinylated proteins in place of streptavidin, but will show higher nonspecific binding 31 REAGENT SETUP BirA BirA was purchased from Avidity.com, or expressed from pET21a-BirA (plasmid available on request from Ting lab) in E. coli as described in Box 1. Store BirA protein aliquots at -80 1C. Streptavidin-Alexa Fluor 568 Make up in PBS at 2 mg ml À1 . Store 50-ml aliquots at -20 1C. Aliquots are stable at 4 1C for 1-2 months.
Avoid repeated freeze-thaws, which increase nonspecific binding (monovalent streptavidin and monovalent streptavidin-Alexa Fluor 568 preparation is described in Box 2). Biotin Store powder at 4 1C. Store 100 mM stocks in DMSO long term at -20 1C but aliquots are stable for at least a few months at 4 1C. It is hard to dissolve biotin to 41 mM in aqueous solution. ATP Make single-use 100-mM aliquots at -80 1C (100Â stock). m CRITICAL Avoid freeze-thawing. ATP will rapidly be hydrolyzed at pH 48.5. Biotin-AMP No commercial supplier. Synthesize according to Coleman and Huang 33 or available on request from Ting lab. Powder should be stored desiccated at -20 1C. Dissolve at 1 mM in PBS pH 7.4 (100Â stock). Solutions are best stored in aliquots at -80 1C. m CRITICAL Avoid pH 48.5 or biotin-AMP will hydrolyze to biotin and AMP. Ampicillin, sodium salt Dissolve at 100 mg ml À1 in water and filter sterilize. Nickel-binding buffer 50 mM Tris base, 300 mM NaCl, adjusted to pH 7.8 with 1 M HCl. Store at 4 1C. (i) Lyse bacteria: resuspend pellet in 4 ml ice-cold nickel-binding buffer with phenylmethylsulfonylfluoride and protease inhibitor cocktail using a motorized pipettor (avoid foaming) and transfer to a 15-ml centrifuge tube. Try to keep bacteria/bacterial lysate at 4 1C for the rest of the purification. Sonicate on ice using a microtip for 6 Â 15 s on 50% pulse. Let the cells cool for 3 min between pulses. This long rest time helps minimize foaming and improves your yield. Do not let the microtip touch the tube walls while it is sonicating. Ensure your solution bubbles during sonication. Addition of 0.5-mm glass beads increases the lysis efficiency. Spin down the bacterial lysate in 1.5-ml microcentrifuge tubes at 14,000g for 10 min at 4 1C. 
BOX 2 | MONOVALENT STREPTAVIDIN EXPRESSION
Overview: Monovalent streptavidin is a heterotetramer consisting of three Dead subunits which do not bind biotin and one subunit which binds biotin with high affinity. Dead (D) and Alive (A) subunits are expressed separately in Escherichia coli, where they form inclusion bodies (Fig. 2c) . D and A inclusion bodies are dissolved in guanidinium hydrochloride, mixed in an appropriate ratio, and refolded by rapid dilution into PBS. The refold creates a statistical mixture of tetramers, and monovalent streptavidin is purified from the other tetramers by a nickel-affinity column, as its single His 6 tag gives it different elution properties to the tetramers with 0, 2, 3 or 4 His 6 tags. (Fig. 4a) . m CRITICAL STEP On 12% gels the streptavidin monomer band will be hard to resolve from the dye-front.
(vii) The preinduction 50 ml sample is concentrated by spinning down at 14,000g for 1 min, the supernatant is removed, and the pellet is resuspended in 20 ml PBS. This 20 ml is mixed with 4 ml of 6Â SDS-PAGE loading buffer and heated at 95 1C for 5 min before loading 12 ml on the gel. Postinduction sample of 50 ml is mixed with 10 ml 6Â SDS-PAGE loading buffer and boiled similarly before loading 12 ml on the gel. There is no need to perform any of these steps in the cold or to add protease inhibitors-inclusion bodies are aggregates that are not susceptible to proteases. m CRITICAL STEP Inefficient washing of inclusion bodies will lead to both poor refolding and poor final purity. Many motorized pipettors are too slow to wash inclusion bodies thoroughly. Keep the pipettor plugged in or it will run down. Resuspend pellets fully in small volumes, and only when it is fully suspended, make up to the final desired volume. If the pellet is initially mixed with 100 ml buffer, it will be impossible to resuspend it properly. Resuspend using 10 ml, not 25 ml, pipettes to maximize shear force. Ideally no lumps should be visible before you proceed to the next step, but do not spend more than a few minutes pipetting at each stage. If you are centrifuging in multiple tubes, try to dislodge the pellets to get them in the same tube so that you only make one effort to suspend them all. Avoid as much as possible making B-PER or wash buffer foam.
(ii) Again resuspend the pellet from all the centrifuge tubes in a total volume of 10 ml B-PER. ' PAUSE POINT You can stop inclusion body purification at any stage: put the pellet at -80 1C and resume next day. Add an extra 10 ml B-PER. Add 800 ml lysozyme (Sigma; 10 mg ml À1 in PBS) and incubate at room temperature for 5 min. Add 100 ml inclusion wash buffer. Mix well by repeatedly inverting the bottle, as the solution is very viscous. Centrifuge at 27,000g for 10 min at 4 1C. (ii) Mix A and D in the appropriate ratio. For each sample in guanidinium, determine the A 280 . To do this, blank the spectrophotometer with guanidinium. Dilute an aliquot of the streptavidin sample B60-fold in guanidinium before measuring, so that A 280 o 1. This is only an estimate of protein concentration because it will depend on how well your protein induced and how well you have washed your inclusion bodies. A sample calculation follows: 2 ml A gave A 280 ¼0 .3, and 2 ml D gave A 280 ¼ 0.5. 5 ml D gives 5 Â 0. Remove insoluble debris by filtering through tissue paper, using a funnel, into a 500-ml Duran bottle and keep the flow-through. It is not necessary to use high quality filter paper for this filtration-regular paper towels perform fine. If the concentration is 43 mg ml À1 , dilute to 3 mg ml À1 to reduce aggregation. Dialyze the supernatant three times in 2 l PBS, each dialysis for 43 h. This dialysis is only because excess ammonium is reported to interfere with the nickel-nitrilotriacetic acid (Ni-NTA) column. Shorter dialysis or running through a NAP-5 column (GE Healthcare) may be sufficient. ' PAUSE POINT Mixed streptavidin tetramers in PBS may be stored indefinitely at À80 1C.
(v) Testing the streptavidin refold. Test purity and yield on an 8% SDS-PAGE gel, loading samples without boiling. The streptavidin tetramer is 56 kDa. It will stay as a tetramer if you add SDS-PAGE loading buffer but do not boil, although it may not run at the same rate as an unfolded 56 kDa protein 42 . ! CAUTION Do not allow sufficient ice to melt that the electrophoresis equipment begins to float in the ice box or there is a risk of electrical shock.
You should see a ladder of different heterotetramers (Fig. 4c, ' mix' lane). Ideally D4, A1D3 and A2D2 will be present in approximately equal amounts, so that the yield of A1D3 is optimized. If D4 is in excess, use more A relative to D in the refold next time. If there is little D4 present, use more D relative to A in the refold next time. m CRITICAL STEP When analyzing streptavidin tetramers by SDS-PAGE, it helps to make sure the gel box is well cooled, because the gel can heat up to 50 1C. Because of the presence of SDS, this temperature is enough to break up the tetramer. Thus surround the gel box with ice, run at 170 V, and make sure every 15 min that the ice is still in contact with the gel box.
(E) Purify monovalent streptavidin on the nickel-affinity column TIMING 2 h for Step E(i-v); 1 d for Step E(vi); 3 h for Step E(vii);
d for
Step E(viii) (i) Load a Poly-prep column with 1.6 ml (packed volume) Ni-NTA agarose.
(ii) Wash with 8 ml nickel-binding buffer, using gravity flow at room temperature. Meanwhile lay out microcentrifuge tubes to collect the fractions.
(iii) Keep 50 ml of your streptavidin for a later gel. Load the remainder of the streptavidin on the column and allow to flow into the column. m CRITICAL STEP Loading the streptavidin onto the resin in batch mode, by rocking, will make the separation of monovalent streptavidin from divalent streptavidin less efficient.
(iv) Let 8 ml SA wash buffer (nickel-binding buffer plus 10 mM imidazole) flow through the column, eluting the rest of D4 and impurities from the inclusion bodies.
(v) Add 12 ml SA elution buffer (nickel-binding buffer plus 75 mM imidazole), eluting monovalent streptavidin. Collect 0.5 ml fractions in 1.5-ml microcentrifuge tubes. To purify divalent streptavidin, follow the elution conditions we described previously 4 . To purify trivalent streptavidin, it is best to put the His 6 tag on the Dead subunit (Dead-His 6 plasmid available on request from the Ting lab), which will lead to more efficient nickel-affinity separation.
(vi) Test fractions on an 8% SDS-PAGE gel. Mix 10 ml samples of each fraction with 2 ml 6Â SDS-loading buffer and load without boiling onto 8% SDS-PAGE gels. In one lane on each gel load the mix of streptavidin tetramers reserved in Step E(iii), as a reference as to which band is which (Fig. 4b) . Pool the fractions containing monovalent streptavidin and dialyze in PBS three times. For a final preparation of 1-2 mg ml À1 , only pool the most concentrated fractions at this stage. If total yield is more important, pool all fractions that show good purity. Insertion can be done either by standard methods, involving ligation of hybridized primers into a restriction site 2 , or by inverse PCR. Inverse PCR can introduce a short peptide sequence into a gene in one step independent of restriction sites present, and so gives great flexibility in the site of AP insertion 36 . The AP sequence must be on the extracellular/luminal face of the protein.
Instead of cloning the AP fusion by yourself, you can use commercial sources of B20,000 human genes with AP inserted at the N terminus or the C terminus. Note that N-terminal fusions will not allow AP display at the cell surface because they will precede the signal sequence.
Biotinylation of AP 2| There are two possibilities for AP biotinylation in mammalian cells: (i) Adding recombinant BirA at the cell surface, or (ii) expression of BirA in the secretory pathway (Fig. 1) . Cotransfection with BirA has the advantage of simplicity-there is no need to prepare BirA protein or biotin-AMP-and the whole experiment is quicker. The advantage of biotinylation by adding BirA protein to the cell surface is that only the cell surface pool of proteins is biotinylated; hence, this pool can be tracked specifically for several hours with only a 0.24-kDa modification. On the basis of experiments with a number of proteins (EphA3, GluR2, low-density lipoprotein receptor), we have not observed a difference in the sensitivity of the two methods of biotinylation. The procedure follows.
(A) AP-fusion biotinylation with BirA added to the cell surface TIMING 2 d for Step 2A(i-ii); 2 min to 2 h for
Step 2A(iii-iv) (i) Plate cells on 7 Â 7 mm 2 coverslips in 48-well plates for transfection.
(ii) Transfect cells with the AP-fusion or establish a stable clone. Transient expression is typically optimal 24-48 h after transfection. Cotransfection with a plasmid encoding a fluorescent protein is a useful way to test transfection efficiency and to identify transfected cells under the microscope. (iii) BirA biotinylation. Wash the cells in PBS pH 7.4 with 5 mM MgCl 2 (PBS-Mg). (For neurons, replace PBS-Mg at every step with Tyrode's buffer.) (iv) Add PBS-Mg with 0.3 mM BirA (from Avidity, or expressed as in Box 1) and 10 mM biotin-AMP for 1-60 min at room temperature or 37 1C. If biotin-AMP is not available, 1 mM ATP and 10 mM biotin can be used instead, although the ATP may cause purinoreceptor activation 3, 37, 38 . The efficiency of biotinylation will depend on the concentration of your target protein at the cell surface and the steric hindrance around the AP. We can typically detect biotinylation after 1-min incubation with BirA and 15-min incubation is saturating. If you need faster biotinylation, you can increase [BirA] to 2 mM. m CRITICAL STEP Adding more biotin or biotin-AMP can impair the signal. With 1 mM biotin, we regularly observe lower signals than with 10 mM biotin. We suspect this is because 1 mM biotin is hard to wash off and may use up some of the streptavidin. Adding more biotin-AMP is unwise for a different reason. Biotin-AMP is an activated intermediate and at 100 mM there is nonspecific biotinylation of Lys on cell surface proteins.
(B) AP-fusion biotinylation with BirA in the secretory pathway TIMING 2 d
Cotransfect the AP fusion with the plasmid delivering BirA to the secretory pathway (pDisplay BirA-ER). We typically transfect with an equal amount of plasmid encoding the AP fusion and BirA-ER. After transfection in serum-free medium, using 
BOX 2 | CONTINUED
(vii) Finally, run the pooled and dialyzed monovalent streptavidin again on an 8% gel, with comparison to a mixed refold, to confirm the purity (Fig. 4c) . The yield of the desired heterotetramer should be B2 mg l À1 of initial culture. Monovalent streptavidin can be stored for a month at 4 1C or indefinitely at -80 1C. Avoid multiple freeze-thaw cycles.
(viii) To label monovalent streptavidin with Alexa Fluor 568, use Alexa Fluor 568 succinimidyl ester exactly according to the protocol for labeling antibodies in the 'Amine Reactive Probes' protocol on the Invitrogen website. This uses a dye:streptavidin molar ratio of 10:1. After reaction, purify labeled streptavidin away from free dye on an NAP-5 column, following manufacturer's instructions, and then dialyze three times, each time for 43 h in 4500-fold excess PBS. This typically gives us three dye molecules attached per streptavidin tetramer. m CRITICAL STEP Ensure that the monovalent streptavidin has been thoroughly dialyzed before labeling and that there are no nucleophiles present, such as Tris or imidazole, which may disrupt succinimidyl ester labeling.
Lipofectamine 2000, we remove the transfection mix and add back normal growth medium, supplementing this with 10 mM biotin. For neuron culture in Neurobasal medium (Invitrogen), there is no need to add any supplementary biotin. Cells are then analyzed the next day.
Detect biotinylation with streptavidin TIMING 15 min to 2 h 3| Wash the cells four times with PBS-Mg to remove any residual biotin/biotin-AMP.
4|
Incubate with PBS-Mg, 1% dialyzed BSA and 10 mg ml À1 (monovalent) streptavidin-Alexa Fluor 568 or an alternative streptavidin conjugate for 5 min at 24 1C.
5| Wash three times with PBS-Mg to remove free streptavidin. You can then incubate the cells for varying times, to allow internalization and trafficking of the AP-fusion protein, or image them immediately, using the same buffer (Fig. 3, panel a) . m CRITICAL STEP Centrifuge all streptavidin conjugates at 14,000g for 5 min at 4 1C immediately before use, to remove aggregates. m CRITICAL STEP Extensive incubation of cells at 44 1C will allow nonspecific internalization of streptavidin-dye conjugate, leading to high nonspecific background. The streptavidin-biotin on-rate is very fast, so 5 min at room temperature should be sufficient. If further receptor trafficking or signaling is not required, streptavidin can be applied for 10 min at 4 1C and washed at 4 1C, for minimum nonspecific background from internalization. Cell lines will generally maintain their morphology for Z1 h at 4 1C, while you stain and image. m CRITICAL STEP Dilute BirA or streptavidin on the day of the experiment. Proteins are unstable at low concentration and get stuck to the sides of the tubes. ? TROUBLESHOOTING Cell fixation (optional) 6| After staining with streptavidin, there is no problem to fix with formaldehyde or methanol, using standard methods. If you intend to biotinylate, then fix with formaldehyde, and then add streptavidin, it is possible to get specific AP-biotin staining, but you need to be careful: even without adding a detergent, such as Triton X-100, formaldehyde can permeabilize the cells. Using electron microscopy-grade methanol-free formaldehyde can help to stop permeabilization. Cells have endogenous biotinylated proteins in the mitochondria and the cytosol 39 , but not in the secretory pathway. If the streptavidin is able to penetrate the plasma membrane, this will cause high background staining. Be sure to do a negative control, omitting BirA to test the specificity of your signal.
If you fix with formaldehyde, then add BirA, and stain with streptavidin, you will probably not get a specific signal because the formaldehyde will react with the Lys on the AP tag and block the biotinylation.
? TROUBLESHOOTING Troubleshooting advice can be found in Table 1 . (Fig. 4a) . If the 10-kDa molecular weight marker is not clearly resolved from the dye-front on SDS-PAGE, cast your gel with a higher percentage of acrylamide, so that it is easy to see the streptavidin induction band away from the dye-front. Plates and media containing 34 mg ml À1 chloramphenicol will help to ensure that the pLysS plasmid is not lost Box 2 C(iii) All of the streptavidin aggregates on refolding into PBS
Inadequate washing of inclusion bodies
The pellet must be fully resuspended at every wash to remove contaminating debris. See the notes in Box 2 B(i) on pipetting, to help you to achieve this. Aggregation can also be caused by adding too much guanidinium hydrochloride to the PBS or adding guanidinium hydrochloride too fast Step Problem Possible reason Solution
ANTICIPATED RESULTS
Typical results for biotinylation of cell surface proteins with BirA, after imaging with monovalent streptavidin, are shown in Figure 3a .
The typical yield from culturing 1 l of bacteria is 40 mg of purified BirA. The typical yield from culturing 1 l of Dead streptavidin and 1/3 l of Alive streptavidin is 2 mg of purified monovalent streptavidin. Induction of Alive and Dead streptavidin is shown in Figure 4a . Elution of monovalent streptavidin from a nickel-affinity column is shown in Figure 4b and SDS-PAGE of purified monovalent streptavidin is displayed in Figure 4c . 
